Markus Renschler Md.

Companies

• Cyteir Therapeutics, Inc.Chief executive officer Feb 24, 2022 to Mar 5, 2024¹
• Cyteir Therapeutics, Inc.President Feb 24, 2022 to Mar 5, 2024¹
• Cyteir Therapeutics, Inc.Board member Jun 17, 2021 to Mar 5, 2024²
• Cyteir Therapeutics, Inc.Officer Jun 17, 2021 to Jun 17, 2021²
• PharmacyclicsSr. VP, Clinical Development May 24, 2006 to Mar 15, 2007³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• CTCyteir Therapeutics, Inc.1,103,661 shares⁴Mar 4, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 4, 2024Exercised options 6,304 shares at $1.69 of Cyteir Therapeutics, Inc.⁴
• Feb 29, 2024Exercised options 2,537 shares at $1.20 of Cyteir Therapeutics, Inc.⁴
• Feb 29, 2024Exercised options 12,607 shares at $1.69 of Cyteir Therapeutics, Inc.⁴
• Nov 20, 2023Exercised options 2,536 shares at $1.20 of Cyteir Therapeutics, Inc.⁵
• Nov 20, 2023Exercised options 27,900 shares at $1.20 of Cyteir Therapeutics, Inc.⁶
• Nov 20, 2023Exercised options 6,304 shares at $1.69 of Cyteir Therapeutics, Inc.⁵
• Nov 20, 2023Exercised options 56,737 shares at $1.69 of Cyteir Therapeutics, Inc.⁶
• Jan 13, 2023Granted 5,000 shares at $1.49 of Cyteir Therapeutics, Inc.⁷
• Dec 21, 2022Exercised options 30,437 shares at $1.20 of Cyteir Therapeutics, Inc.⁸
• Dec 21, 2022Exercised options 106,345 shares at $1.03 of Cyteir Therapeutics, Inc.⁸